Osaic Holdings
EW icon

Osaic Holdings’s Edwards Lifesciences EW Stock Holding History

Osaic Holdings’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.22M Buy
57,651
+16,235
+39% +$1.36M 0.01% 1498
2026
Q1 		$3.32M Sell
41,416
-1,786
-4% -$147K ﹤0.01% 1657
2025
Q4 		$3.68M Sell
43,202
-988
-2% -$81.1K 0.01% 1610
2025
Q3 		$3.5M Buy
44,190
+2,196
+5% +$172K ﹤0.01% 1746
2025
Q2 		$3.28M Sell
41,994
-3,711
-8% -$277K 0.01% 1532
2025
Q1 		$3.31M Sell
45,705
-40,061
-47% -$2.87M 0.01% 1297
2024
Q4 		$5.88M Buy
85,766
+22,653
+36% +$1.59M 0.01% 946
2024
Q3 		$4.16M Sell
63,113
-26,351
-29% -$1.91M 0.01% 1163
2024
Q2 		$8.26M Sell
89,464
-17,442
-16% -$1.54M 0.02% 722
2024
Q1 		$10.2M Sell
106,906
-99,052
-48% -$8.32M 0.02% 677
2023
Q4 		$15.7M Sell
205,958
-143,984
-41% -$10M 0.03% 570
2023
Q3 		$24.2M Buy
349,942
+88,933
+34% +$7.15M 0.04% 472
2023
Q2 		$24.6M Buy
261,009
+1,401
+0.5% +$122K 0.04% 389
2023
Q1 		$21.5M Buy
259,608
+16,557
+7% +$1.3M 0.04% 428
2022
Q4 		$18.1M Buy
243,051
+33,037
+16% +$2.55M 0.04% 470
2022
Q3 		$17.4M Sell
210,014
-22,155
-10% -$2.13M 0.04% 432
2022
Q2 		$22.1M Buy
232,169
+19,641
+9% +$2.03M 0.05% 353
2022
Q1 		$27.5M Sell
212,528
-10,635
-5% -$1.19M 0.05% 329
2021
Q4 		$28.9M Buy
223,163
+32,539
+17% +$3.8M 0.05% 321
2021
Q3 		$21.6M Buy
190,624
+11,138
+6% +$1.27M 0.05% 372
2021
Q2 		$18.6M Buy
179,486
+6,509
+4% +$614K 0.04% 405
2021
Q1 		$14.5M Sell
172,977
-10,510
-6% -$889K 0.03% 449
2020
Q4 		$16.7M Sell
183,487
-18,251
-9% -$1.51M 0.04% 366
2020
Q3 		$16M Buy
201,738
+9,673
+5% +$755K 0.05% 333
2020
Q2 		$13.3M Buy
192,065
+4,154
+2% +$295K 0.04% 347
2020
Q1 		$11.1M Buy
+187,911
New +$13.6M 0.05% 345

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Osaic Holdings's EW Position: Q2 2026 in Review

Osaic Holdings increased its Edwards Lifesciences (EW) stake by 39% in Q2 2026, buying an estimated $1.36M and bringing the position to 57,651 shares worth $5.22M. The position accounts for 0.01% of the portfolio, ranked #1498.

Osaic Holdings first reported a position in EW in Q1 2020 and has held it in 26 quarters since. The position peaked at $28.9M in Q4 2021. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Osaic Holdings held 57,651 shares of Edwards Lifesciences worth $5.22M as of Q2 2026.
  • Osaic Holdings bought 16,235 Edwards Lifesciences shares in Q2 2026, an estimated $1.36M.
  • Edwards Lifesciences made up 0.01% of Osaic Holdings's portfolio in Q2 2026, its #1498 holding.
  • Osaic Holdings first reported a position in Edwards Lifesciences in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Edwards Lifesciences position peaked at $28.9M in Q4 2021.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.